$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 33.33%. Longby EPSMomentumPublished 0
Shorting Gilead. GILDIndeed. B Wave in a zigzag form appears to be completed. We are going down to one extent to another. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.Shortby Rykin_CapitalUpdated 2
$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%. Longby EPSMomentumPublished 0
14/4/2022 NASDAQ (GILD)Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price. Entry Price: $61.83 Target Price: $62.45 Stop Loss: $61.21Longby Airecap_HyperUpdated 0
28/3/2022 NASDAQ (GILD)Short (Entry Price) below the black line and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price. Entry Price: $58.87 Target Price: $58.47 Stop Loss: $59.54Shortby Airecap_HyperUpdated 0
$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 62.5%.Longby EPSMomentumPublished 0
Bias more on upside. 05th March 2022 Gilead 56 final support. worth to take risk price between 56-60 TP64 & 68 Nimble safeLongby probabilitytaPublished 112
Gilead Sciences: Boom Times Ahead? - Potential Run to +$110 areaNASDAQ:GILD Early Long Idea on Gilead Sciences Gilead has navigated 2/3rds of a huge arc that has been forming since 2015, and the arc is beginning to slope vertical. Price navigated the yellow pitchfork on the way down, and now is beginning to be directed by the purple upsloping fork. Weekly Stoch RSI is approaching oversold levels. I will wait for a momentum signal or another strong arc retest before going long with a long dated call / LEAP. Just an idea right now, with a lot of upside. Longby Cousin_Fat_FatUpdated 1
ABC BullishTarget is D GILD has broken the neckline of an inverse head and shoulders pattern and possibly forming a cup. No recommendationby lauraleaPublished 222
Gild is at it's final face of accumulation?I believe Gilead has made it's final low on Oct 29th. These Wyckoff accumulation patterns are very powerful reversal patterns. I will be more convinced if price breaks above the red line resistance. If that that happens, , I will start adding GILD on my portfolio. Good luck everyoneby FreedomBuilderPublished 2
GILD Gilead Sciences long tradenot sure about the WXY correction wave because the first zigzag is not really one (c truncated don't like it so much but bc=61,8% of ab so also not that bad) anyway triangle in formation right now so possible trace with a low risk ratio we would assume a wave 3 is coming 1) either enter then the triangle is broken with a stop under the e branch of the triangle 2) or anticipate and enter now with a stop under the c branch of the triangle target 161,8% of wave 1 around 77€ Example: entry point = buy over 69,5€ target = 77€ stop = 66,5€ Longby FabienGoUpdated 2
GILD DOUBLE BOTTOMIdentification of a double bottom pattern, downtrend line and EMA 200 trend indicator in GILDby paiclas71Published 0
GILD LONGWe had a daily, weekly and now monthly breakout in Gilead Sciences - I think its reasonable to be long here - could/should trend into January 22' Longby TiMMiTUpdated 1
Time to Cool OffI think GILD is going to want to cool off a bit now after it's nice run. RSI is overbought, Large sell wick on the daily, bearish divergence. We may see a drop over the next several days back down to the bottom of the trend line before it goes back up again.by dtomasino5Published 1
Monthly chart breakout GILDGILD has broken out of its ascending triangle on the monthlyLongby ali925MPublished 1
GildGets a daily close above 70.69 could be breaking out of a big wedge. Keep eyes on this for a potential big move. Keep stops tight below 68by ErictaylorPublished 0
GILDIf it holds the level, you can consider buying approximately, roughly speaking, from 71 . 7/30/21 RBC Capital Maintains Outperform 84.0 7/30/21 SVB Leerink Maintains Outperform 77.0 4/30/21 SVB Leerink Maintains Outperform 74.0Longby S0rt0Published 0
Gilead - Another capital preservation candidateLooks like the base is formed and a reversal is on track. Target 1&2 - Dotted lines. Longby XtanlyPublished 0
The longer the base ...Trend(OBV) uses True Strength Index to analyze "On-Balance-Volume", which measures buying and selling pressure as a cumulative indicator. The Trend(OBV) crossed above its signaling Bollinger Band. This is a sign of bullish character. In addition, both Bollinger band and Donchian channel of the Trend(OBV) display squeezes. Can GILD break out and rally from the current base? Longby KhanhC.HoangPublished 1
GILD: Triangle Within A Triangle Plus VolumeFUNDAMENTALS: GILD ( Gilead Sciences ) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D. ***Revenue is also generated when more people catch and/or are dying of covid with their covid treatment called Veklury. Revenue soared around $1.5 billion from Veklury alone. Target 80 or 165Longby RocketmanUpdated 3